SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015012
Filing Date
2023-08-16
Accepted
2023-08-16 07:45:12
Documents
13
Period of Report
2023-08-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230816x8k.htm   iXBRL 8-K 32536
  Complete submission text file 0001558370-23-015012.txt   163778

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20230816.xsd EX-101.SCH 3818
3 EX-101.DEF elev-20230816_def.xml EX-101.DEF 2823
4 EX-101.LAB elev-20230816_lab.xml EX-101.LAB 17910
5 EX-101.PRE elev-20230816_pre.xml EX-101.PRE 11887
7 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230816x8k_htm.xml XML 5048
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 231176498
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences